{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.158C>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "C",
            "alt": "T",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in a-synuclein (a-syn) gene"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Familial Parkinsonâ€™s disease",
    "MONDO": "MONDO:0005190"
  },
  "Experiment Method": [
    {
      "Assay Method": "Immunohistochemical analysis",
      "Material used": {
        "Material Source": "Patient-derived brain tissue",
        "Material Name": "Brain tissue from A53T mutation carriers",
        "Description": "Immunohistochemical analysis was performed on brain tissue from patients with the A53T mutation."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Accelerated fibrillization of a-syn and tau proteins",
          "Result Description": "Accumulation of insoluble filamentous a-syn and nitrated a-syn was observed in A53T mutation carriers. Filamentous tau protein accumulation was also noted."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Absence of insoluble filamentous a-syn and tau proteins",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of insoluble filamentous a-syn and tau proteins",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Biochemical analysis",
      "Material used": {
        "Material Source": "Patient-derived brain tissue",
        "Material Name": "Brain tissue from A53T mutation carriers",
        "Description": "Biochemical analysis was performed on brain tissue from patients with the A53T mutation."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased fibrillization of a-syn and tau proteins",
          "Result Description": "Quantification of insoluble a-syn and tau proteins showed elevated levels in A53T mutation carriers compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal levels of insoluble a-syn and tau proteins",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Elevated levels of insoluble a-syn and tau proteins",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Ultrastructural analysis (electron microscopy)",
      "Material used": {
        "Material Source": "Patient-derived brain tissue",
        "Material Name": "Brain tissue from A53T mutation carriers",
        "Description": "Ultrastructural analysis was performed on brain tissue from patients with the A53T mutation."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.158C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Formation of pathological aggregates in a-syn and tau proteins",
          "Result Description": "Ultrastructural analysis revealed the formation of pathological aggregates and filamentous structures in A53T mutation carriers."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Absence of pathological aggregates",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Presence of pathological aggregates",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}